These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 933813)

  • 1. [Experience in the treatment of leg ulcer with Stutgeron].
    Mund-Hoym WD
    Med Welt; 1976 Jun; 27(25):1251-4. PubMed ID: 933813
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cinnarizine and phosphatidyl choline in the treatment of cerebral arteriosclerotic pathology and arteriosclerosis of the lower extremities. Comparative study].
    Ciammaichella A; Solitro A; Arcuri P
    Minerva Cardioangiol; 1975 Mar; 23(3):191-200. PubMed ID: 1128771
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopharmacological examination of Stugeron (Cinnarizine) in geriatric patients.
    Graber H; Ternovszky E
    Ther Hung; 1978; 26(3):124-6. PubMed ID: 725815
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of cinnarizine in some vascular diseases].
    Triandaf I; Cosma M; Triandaf N
    Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the use of cinnarizine dihydrochloride in the treatment of arteriosclerotic cerebropathy].
    Di Lorenzo S; Costagliola A; Lampasi D; Alfano S
    Minerva Cardioangiol; 1974 Dec; 22(12):867-70. PubMed ID: 4459730
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine).
    Kalimo K; Jansen CT
    Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of a single dose of cinnarizine on the peripheral flow and renogram of arteriosclerotic patients].
    Indovina I; Salerno L; Custro N
    Minerva Cardioangiol; 1980 May; 28(5):355-8. PubMed ID: 7207825
    [No Abstract]   [Full Text] [Related]  

  • 11. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
    Verhaegen H; Reyntjens A; Horig C; Pötsch W
    Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent claudication: a controlled study in parallel time of the short-term and long-term effects of cinnarizine.
    Barber JH; Reuter CA; Jageneau AH; Loots W
    Pharmatherapeutica; 1980; 2(6):401-7. PubMed ID: 7433479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intermittent claudication. Attempt at an objective vue of the disease and the possible treatment results with Sibelium].
    Loots W; Dom J; Hörig C
    Med Welt; 1980 Feb; 31(5):189-92. PubMed ID: 7366398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin].
    Palleschi M; Marci M; Ceraso C; Passacantilli A; Marin P
    Clin Ter; 1984 Aug; 110(3):215-20. PubMed ID: 6237860
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic experience with Stugeron.
    Abrányi I
    Ther Hung; 1973; 21(3-4):117-20. PubMed ID: 4806419
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-invasive diagnosis and medical therapy of cerebral and/or peripheral atherosclerotic vasculopathies].
    Rezzo R; Stabilini L; Bertoglio C; Ruben G; De Gregori M; Fontana G; Gori A; Petrilli GL
    Clin Ter; 1984 Dec; 111(6):495-511. PubMed ID: 6396028
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experiences with flunarizine in the treatment of otoneurologic symptoms].
    Materna F
    Med Welt; 1981 Jul; 32(29):1157-60. PubMed ID: 7266354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.